Benzinga | Aug 3, 2020 12:47PM EDT

Earnings Outlook for CytoSorbents

CytoSorbents (NASDAQ: CTSO) releases its next round of earnings this Tuesday, August 04. Here's Benzinga's essential guide to CytoSorbents's Q2 earnings report.

Earnings and Revenue

CytoSorbents's EPS is expected to be at $-0.08 on sales of $9.66 million, according to Wall Street analysts.In the same quarter last year, CytoSorbents posted a loss of $-0.110 per share on sales of $6.23 million. If the company were to post earnings in-line with the consensus estimate when it reports Tuesday, EPS would be down 27.27%. Sales would be up 38.0% from the year-ago period. Here's how the company's reported EPS has compared to analyst estimates in the past:

Quarter Q1 2020 Q4 2020 Q3 2019 Q2 2019EPS Estimate -0.13 -0.17 -0.22 -0.14EPS Actual -0.10 -0.12 -0.21 -0.11Revenue Estimate 7.00 M 6.80 M 6.66 M 6.17 MRevenue Actual 8.71 M 7.43 M 6.09 M 6.23 M

Stock Performance

Over the last 52-week period, shares are up 45.87%. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.

Don't be surprised to see the stock move on comments made during its conference call. CytoSorbents is scheduled to hold the call at 16:45:00 ET and can be accessed here: https://viavid.webcasts.com/starthere.jsp?ei=1338510&tp_key=e984a6c557